Business Context and Reporting Period
Company: Greenlight Capital Re, Ltd. (GLRE)
Reporting Period: Quarter ended March 31, 2008
Business Model: Cayman Islands-based specialty property and casualty reinsurer utilizing a value-oriented investment strategy (long undervalued/short overvalued securities).
Segment: Single operating segment: Property & Casualty Reinsurance.
Key Financial Metrics
| Metric | Q1 2008 | Q1 2007 |
|---|---|---|
| Net Premiums Written | $61.5 million | $24.3 million |
| Net Premiums Earned | $27.5 million | $20.9 million |
| Total Revenues | $21.7 million | $6.5 million |
| Net Investment Loss | $(5.8) million | $(14.4) million |
| Net Loss | $(4.8) million | $(13.1) million |
| Loss Per Share (Basic/Diluted) | $(0.13) | $(0.61) |
| Combined Ratio | 96.4% | 94.1% |
| Total Assets | $1,058.7 million | $1,094.1 million (Dec 31, 2007) |
| Shareholders' Equity | $601.4 million | $605.6 million (Dec 31, 2007) |
| Cash & Cash Equivalents | $59.7 million | $64.2 million (Dec 31, 2007) |
| Restricted Cash | $273.0 million | $371.6 million (Dec 31, 2007) |
Material Changes vs. Prior Period
- Profitability Improvement: Net loss narrowed significantly by $8.4 million compared to Q1 2007, driven by a $8.6 million reduction in investment losses and $1.2 million higher underwriting income.
- Underwriting Growth: Gross premiums written increased 86% to $70.8 million, with net premiums written rising 153% to $61.5 million. This reflects portfolio expansion and a shift in mix toward severity business.
- Investment Performance: Net investment loss improved from 4.2% of portfolio value in Q1 2007 to 0.9% in Q1 2008. Realized gains/losses and unrealized movements contributed to a net loss of $5.8 million.
- Expense Increases: General and administrative expenses rose 50% to $4.5 million, attributed to personnel expansion, public company costs, and higher employee bonuses related to 2007 performance.
- Loss Ratios: The frequency business loss ratio improved to 44.5% (from 53.8%), while the severity business loss ratio increased to 43.3% (from 8.4%) due to portfolio composition changes and loss development on specific contracts.
Guidance, Outlook, and Risks
- Market Outlook: Management anticipates excess capacity in the P&C reinsurance market, potentially exerting downward pricing pressure. However, they expect to find attractive opportunities in casualty, property catastrophe, and professional liability lines.
- Strategic Focus: The company intends to maintain underwriting discipline and capitalize on market disruptions, particularly in Health markets and the Cayman Islands captive market.
- Capital Strategy: No current plans to issue equity or debt; operations are expected to be funded by operating cash flow. Dividends are not currently expected.
- Key Risks:
- Investment Volatility: Exposure to equity price risk; a 10% decline in listed equity prices would reduce portfolio fair value by approximately $36.3 million.
- Credit Risk: Exposure to prime brokers and swap counterparties; $133.5 million in letters of credit are outstanding, secured by $250.4 million in pledged assets.
- Reserve Uncertainty: Loss reserves are estimates; final settlement may vary materially, particularly for severity business.
- Concentration: Significant exposure to natural peril events (maximum aggregate loss exposure of $70.5 million as of May 1, 2008).
Investor Verification Checklist
- Investment Portfolio Composition: Verify the current fair value and concentration of long/short equity positions and private equity commitments ($20.7 million remaining).
- Loss Reserve Adequacy: Monitor development of loss reserves, particularly for severity contracts and natural peril exposures.
- Liquidity and Collateral: Confirm the status of the $425 million letter of credit facilities and the sufficiency of pledged assets ($250.4 million) to cover outstanding letters of credit ($133.5 million).
- Underwriting Mix: Track the shift between frequency and severity business and its impact on the combined ratio volatility.
- Related Party Fees: Review the impact of the joint venture with DME Advisors, LP, including management fees ($2.5 million in Q1 2008) and performance compensation structures.